This is a restricted members post. Join
Analyst Call 13/11/24 Summary
Summary of Nuix Shareholder / Analyst Call 13/11/24 Here are the 10 key points from the Nuix Shareholder / Analyst Call 13/11/24: Meeting Overview: The meeting was led by Nuix’s Chairman, Robert Mactier, who opened by acknowledging traditional land custodians and outlined the meeting agenda. The meeting was conducted in a hybrid format, allowing both …
Earnings Call 02/09/24 Summary
Summary of Titomic 2024 Earnings Call 02/09/24 Here’s a summary of the ten most relevant points from the Titomic 2024 Earnings Call 02/09/24: Technological Advancements: Titomic’s cold spray technology is proving transformative, offering significant advantages over traditional casting and forging, particularly for titanium, Inconel, and Invar components. This includes faster time-to-market, cost reductions, and enhanced sustainability through …
Titomic Earnings Call 02/09/24
Titomic Earnings Call 02/09/24 Otherwise, click HERE for a 10 point summary. Operator Welcome all to Titomic’s Results Webinar for Financial Year 2024. Today’s presenters are Managing Director, Herbert Koeck, and our CFO, Geoff Hollis, who will discuss Titomic’s performance for FY ’24 and our outlook. The presentation will be followed by a brief Q&A …
Special Call 22/10/24 Summary
Special Call 22/10/24 Summary Here’s a summary of the ten most relevant points from the Neuren Pharmaceuticals Special Call 22/10/24: Neuren’s Mission: Neuren Pharmaceuticals focuses on treating neurodevelopmental disorders caused by genetic abnormalities that severely impact basic functions such as walking, talking, and eating. The goal is to address syndromes holistically by improving brain connectivity …
Neuren Pharmaceuticals Special Call 22/10/24
Neuren Pharmaceuticals Special Call 22/10/24 Otherwise click HERE for a 10 point summary. Jonathan Pilcher Great. Thanks very much, Ian, and good morning, everyone. Thanks for spending the time to listen to the Neuren story. Really appreciate it. Before I start, I would have to remind you that there are some forward-looking statements in the …
Analyst Call 01/11/24 Summary
Analyst Call 01/11/24 Summary Here’s a summary of the ten most relevant points from the Austal Shareholder / Analyst Call 01/11/24: Leadership Transition: John Rothwell, founder and former chair of Austal, stepped down after 37 years. Richard Spencer, former U.S. Secretary of the Navy, was introduced as the new chair. Historical Achievements: Austal’s journey began …
Crispr NASDAQ:CRSP Analysis
About Crispr NASDAQ:CRSP CRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR-Cas9 technology. Their work targets genetic diseases by editing DNA to correct or modify disease-causing genes. Key programs include treatments for beta-thalassemia and sickle cell disease, focusing on producing healthy blood cells. They are also advancing cancer immunotherapies by engineering immune cells …
Austal Limited Analyst Call 01/11/24
Austal Limited Analyst Call 01/11/24 Otherwise, click HERE for a 10 point summary. John Rothwell Good afternoon, ladies and gentlemen. They’re probably not all that many people that don’t know me, but my name is John Rothwell, and I’m the founder and the past Chair, I said correctly. So we have — I would like …
Nuix Analyst Call 13/11/24
Nuix Analyst Call 13/11/24 Otherwise click HERE for a 10 point summary. https://www.nuix.com/ Robert Mactier Good morning, everyone, and welcome to the Nuix 2024 Annual General Meeting. My name is Rob Mactier, and I’m Nuix’ Chairman. And I begin today by acknowledging the Gadigal people of the Eora Nation, traditional custodians of the land on …
Neuren Pharmaceuticals (ASX:NEU) Analysis
This is a restricted members post. Join
How I use stocksunderthehood.com
Introduction StocksUnderTheHood.com has evolved significantly in its first 18 months. What began as a personal tool has grown into a platform that helps both me and a growing number of others navigate the market more efficiently. As my web and coding skills have improved, I’ve focused on automating key market tasks—far exceeding my initial expectations. …
QUALITY Model Update 7
This is a restricted members post. Join
3EMA Trading Strategy
A trend trading strategy known as the 3EMA Trading Strategy forms the basis for the moving averages employed on the charts in the Fact Sheets section and throughout this website. EMA stands for “Exponential Moving Average”. EMAs provide a way to smooth out price movements and provide us with a trend-line that is a bit …
Quick Take: QCFSep24 (ASX:DRO)
This content is restricted to supporters of stocksunderthehood.com Join
ETFs: Are They Distorting Financial Markets?
This is a restricted members post. Join
Quick Take: Oct2024 ASX:ZIP
This content is restricted to supporters of stocksunderthehood.com Join
Beamtree Holdings (ASX:BMT) Analysis
This is a restricted members post. Join
What to buy?
Introduction Buying is the fun and easy part. It’s really not that hard to find stocks that are going up and simply “jump on the bus.” I guess the art for the investor, as opposed to the trader, is finding stocks that have the greatest potential to go up for as long as possible. Buying …
QUALITY Model Update 6
This is a restricted members post. Join